, , , , , , , , ,

English: Logo of the .

English: Logo of the . (Photo credit: Wikipedia)

A petition is now before the Food and Drug Administration that will re-label opioid analgesics (narcotic pain medications) to determine the amount of pain relief appropriate for you regardless of the disease from which you suffer.

The petition, submitted by Physicians for Responsible Opioid Prescribing (PROP), requests three specific changes to opioid analgesic labels:

1- That they no longer be prescribed for “moderate” noncancerous pain, but only for “severe” noncancerous pain

2- That the maximum allowable dosage per day be equivalent to 100 mg of morphine for noncancerous pain

3 – That this medication can only be used for a maximum duration of 90 DAYS.

What this petition appears to mandate is a “one size fits all” prescribing mentality, which DOES NOT benefit the chronic pain patients in general and CRPS patients, in particular. ~Jim Broatch, Executive Vice President and Director

The RSDSA (Reflex Sympathetic Dystrophy Syndrome Association) is asking that ANYONE who is worried by this possible outcome to send a letter immediately and contact all family and friends and ask them to do the same. YOUR health and ability to function with many diseases are at risk.

The sample letter below is provided by the RSDSA. Mr. Broatch said in a recent email, “For those of you who would like to send your own personal response regarding PROP to the FDA, we encourage you to stress the specific details that your medication enables you to do and that without it you would be unable to do.”

My name is  _______. As a person  who suffers with the chronic and  yet incurable pain of  CRPS,  I ask the FDA to deny the PROP petition. I use opioids as prescribed by my physician allowing me to function better and partake in life in ways I would be unable to do without this prescribed care.

To send your comments to the FDA click here. The category to use for your response is Individual Consumer.

Your immediate action to this issue will make a difference. To read the PROP petition, click here.
The RSDSA chose to oppose the PROP petition on behalf of our members. On Wednesday, October 10th, The RSDSA sent this opposition letter to the FDA. Click here to read the letter.